Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.
American Well Corporation reports developments for Amwell, a SaaS-based software platform for technology-enabled healthcare used by payers and health systems. Company updates center on quarterly and annual operating results, business reviews, investor conference participation, and equity-compensation actions such as inducement-plan grants.
The Amwell platform combines software and services that support virtual care programs across the care continuum, including virtual primary care, urgent care, clinical partner programs, scheduling, provider workflows, prescribing, and treatment-guideline reference tools. News about AMWL commonly connects these platform capabilities with payer and health system relationships, partner clinical programs, and management commentary on technology-enabled care delivery.
Amwell (NYSE: AMWL) is expanding its partnership with Tyto Care to improve remote medical exams. The collaboration will introduce new integrations and workflows, enhancing virtual care capabilities for providers. Amwell will also become a reseller of Tyto Care's examination devices, offering tools for comprehensive health assessments. The initiative aims to provide more holistic care, especially for urgent and primary needs, as telehealth adoption increases during the COVID-19 pandemic. Amwell services will reach thousands of clients, enhancing patient-provider interactions remotely.
Amwell announced the closing of its upsized initial public offering (IPO) on September 21, 2020, selling 47,405,555 shares of Class A common stock at $18.00 per share. This includes the underwriters' option to purchase an additional 6,183,333 shares, resulting in gross proceeds of approximately $922 million for Amwell. Additionally, a private placement with Google LLC raised $100 million through the sale of 5,555,555 shares of Class C common stock. The shares began trading on the NYSE under the symbol 'AMWL' on September 17, 2020.
Amwell, a telehealth leader, announced the pricing of its upsized IPO at $18.00 per share, raising approximately $742 million before expenses. The offering includes 41,222,222 shares, with an additional 30-day option for underwriters to purchase up to 6,183,333 shares. Shares will start trading on the NYSE under the symbol 'AMWL' on September 17, 2020, and the offering is expected to close on September 21, 2020. The SEC declared the registration statement effective on September 16, 2020.